ClinicalTrials.gg
DrugRead study by study

Pertuzumab clinical trials

Also written Perjeta, RO4368451 and rhuMAb 2C4.

studies test it
156
open now
38
in phase 3
33
first study started
2001
Related medicines add 1 study

Counted the way a researcher would: Pertuzumab with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

ClinicalTrials.gov finds 448 studies for pertuzumab. How that becomes 156 here

Every study that search finds has been read, apart from the 1 newest, to see whether and how it gives pertuzumab. ClinicalTrials.gov counts as of Nov 16, 2026. How drug pages count

  1. 448Found by its intervention search · See all 448 hereIt also reads titles, arm labels, keywords and descriptions, and counts the drug’s other names. Of these, 347 name it in an intervention entry. The counts it shows beside each synonym overlap: a study writing two names counts under both.
  2. −20
    Mention it without giving it — earlier treatment, a protocol code, a title naming another drug
  3. 428Give pertuzumab to participants
  4. −44Observe patients on it, or give it outside a trial
  5. −4Use it as a tool: an imaging tracer or a test of drug response
  6. −33Compare another treatment with it
  7. −191Give it beside what is tested
  8. 156Test it: the count on this site

Get an email when these change. Save the pertuzumab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
8 Jun 2012 · PERJETA · BLA 125409 (FDA, Drugs@FDA)
European Union
4 Mar 2013 · Perjeta · EMEA/H/C/002547 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Pertuzumab
95
2C4
7
Omnitarg
6
2C4 Antibody
4
Monoclonal Antibody 2C4
4

Brand

Perjeta
58

Development codes

RO4368451
12
rhuMAb 2C4
10
RG1273
1
SYSA1901
1

Biosimilars

HS627
2
BCD-178
2
HLX11
2
EG1206A
2
TQB2440
1

Studies by the year they started

155 studies that test it; most in 2021 (13); 1 more planned to start later

Studies that test pertuzumab, by start year
YearStudies
20011
20035
20042
20054
20063
20071
20081
20094
20105
20114
20125
20138
201410
201511
20169
20175
20187
20191
202010
202113
202212
202310
20247
20259
20268

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
22
Phase 2
100
Phase 3
33
Phase 4
3
No phase
6

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 57 · Other 99

Hoffmann-La Roche (32) · Genentech, Inc. (11) · Dana-Farber Cancer Institute (7) · National Cancer Institute (NCI) (4) · MedSIR (3) · The Netherlands Cancer Institute (3) · City of Hope Medical Center (2) · H. Lee Moffitt Cancer Center and Research Institute (2)

Often tested with

Tested in the same studies.

Trastuzumab (89) · Ado-Trastuzumab Emtansine (15) · Paclitaxel (15) · Atezolizumab (14) · Pertuzumab/Trastuzumab/Hyaluronidase-zzxf (10) · Olaparib (10) · Cobimetinib (10) · Docetaxel (9)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 11 phase 3 studies under way

Pertuzumab is the comparator. A study of two new drugs counts under both.

New treatments tested with it · 8 most studied

New when their studies opened, with pertuzumab beside them; studies of each.

Reaching primary completion within a year · 17, 5 in phase 3

Studies that test pertuzumab, phase 3 first.

Studies

Open first, then newest update. How each study uses pertuzumab has had a first review, but it may not be perfect: check the study record before relying on it for anything important, and report a problem from its row. Some give it without naming it in an intervention entry: those were found by reading the record.

Testing it · 156

See all 156 studies that test pertuzumab →

Behind its US label · 5 — the studies the FDA label of PERJETA describes

From the Clinical Studies section of PERJETA (2026-04), as openFDA has it. A study the site does not hold is left out.

Tested on its own · 19 — no other medicine in its arm
Tested with established drugs · 32 — they are given beside it

Showing 20 of 32. See all 32 →

Tested in a combination · 104 — another drug in the study is under test too

Showing 20 of 104. See all 104 →

Beside an established treatment under test · 85 — an approved drug, surgery or radiation is what the study tests

Tested with pertuzumab: Surgery or a procedure 14 · Trastuzumab 8 · Carboplatin 8 · Radiation 7 · Paclitaxel 7 · atezolizumab 7 · trastuzumab deruxtecan 5 · Albumin-Bound Paclitaxel 5

Showing 20 of 85. See all 85 →

Beside a new treatment under test · 83 — a new drug, cell therapy or vaccine is what the study tests

New treatments tested with pertuzumab: trastuzumab rezetecan 10 · pyrotinib 7 · Ado-Trastuzumab Emtansine 3 · Anti-HER2 Antibody-drug Conjugate BL-M07D1 3 · culmerciclib 3 · inavolisib 2 · dalpiciclib 2 · HRS-4508 2

Showing 20 of 83. See all 83 →

Beside supportive care · 14 — a supportive treatment or test is studied
One option of several · 8 — a test or a strategy chooses among drugs
Given beside what is tested · 1 — usual care or a partner of the new treatment
As the comparator · 33 — what is tested is compared with pertuzumab

Showing 20 of 33. See all 33 →

Observed · 44 — patients on it are followed, or it is given outside a trial

Showing 20 of 44. See all 44 →

As a tool · 4 — an imaging tracer or a test of drug response

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call pertuzumab · ClinicalTrials.gg INT004642

  • MeSH (NLM) C485206pertuzumabConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) K16AIQ8CTMPERTUZUMABConfirmed FDA, NLM, Wikidata
  • RxNorm 1298944Confirmed FDA, Wikidata
  • Wikidata Q1998021pertuzumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C38692PertuzumabOne source FDA
  • DrugBank DB06366One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.

Start the discussion